Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 6,401

Document Document Title
WO/2010/028487
The instant application is directed to bidesmosidic betulin and betulinic acid saponin derivatives of formula (I), and use thereof as antitumor agents. In particular, said compounds are effective in treating lung carcinomas, colorectal a...  
WO/2010/030704
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Z1, Z2, Z3, Z4, R1, R2 and R3 are as d...  
WO/2010/029185
A compound of the following formula or a salt, solvate or formula (I) and a pharmaceutical composition containing said compound. It concerns also its use in the treatment of cancer and/or of pathological angiogenesis and/or in promoting ...  
WO/2010/027108
Disclosed are a method for sensing saccharide-binding protein easily, quickly, and with high sensitivity, and a fluorescent compound necessary for this sensing. Specifically, disclosed is a method for sensing saccharide-binding protein t...  
WO/2010/023162
A new process for extracting and purifying glucosinolates from plant material, preferably broccoli sprouts or seeds is described. An alcoholic extract is adsorbed onto a basic resin and eluted with ammonia. Optionally, the alcoholic extr...  
WO/2010/023594
Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).The compounds disclosed her...  
WO/2010/018474
The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the co...  
WO/2010/018474
The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the co...  
WO/2010/018438
The invention relates to the tetrazole glycosides derivatives, which are inhibitors of Sodium dependent glucose co transporter (SGLT), particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 wit...  
WO/2010/018435
The invention relates to the O-glucosylated amide derivatives, which are inhibitors of Sodium dependent glucose co transporter (SGLT), particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 wit...  
WO/2010/014814
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2010/014814
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2010/014814
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2010/005560
Phytoplankton represent a potential source of bioactive compounds. The present disclosure provides, inter alia, methods for identifying glycerolipids and apoptosis- inducing sphingosine-like lipids from virally-infected phytoplankton.  
WO/2010/004433
Hydrophobically enhanced aminoglycosides have been prepared and shown to be effective antibacterial agents. These agents may be used in the treatment or prevention of various bacterial infections. Methods of preparing these agents also p...  
WO/2009/156324
Described is the use of benzotropolone and their derivatives, especially the compounds of formula (1); wherein R2, R3, R4, R5 and R6 independently of one another are hydrogen; OH; C1-C30alkyl, C2-C30al- kenyl, C1-C30alkoxy, C3-C12cycloal...  
WO/2009/156324
Described is the use of benzotropolone and their derivatives, especially the compounds of formula (1); wherein R2, R3, R4, R5 and R6 independently of one another are hydrogen; OH; C1-C30alkyl, C2-C30al- kenyl, C1-C30alkoxy, C3-C12cycloal...  
WO/2009/153434
The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt thereof, to the method for preparing same ...  
WO/2009/153434
The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt thereof, to the method for preparing same ...  
WO/2009/153509
Composition (C) comprising, per 100% of its weight: - from 10 wt% to 95 wt%, more particularly from 70 wt% to 95 wt% of one or more alcohol ethers of glycerol of formula (II): in which R1 represents a linear or branched, saturated or uns...  
WO/2009/153509
Composition (C) comprising, per 100% of its weight: - from 10 wt% to 95 wt%, more particularly from 70 wt% to 95 wt% of one or more alcohol ethers of glycerol of formula (II): in which R1 represents a linear or branched, saturated or uns...  
WO/2009/153434
The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt thereof, to the method for preparing same ...  
WO/2009/150022
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/150023
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/150023
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/150022
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/143630
Compounds produced by combining imino sugars and creatine and salts thereof are herein disclosed. The compounds being in the form of creatine imino sugar amides and the salts being combinations of various creatine imino sugar amides with...  
WO/2009/143930
A process for the preparation of compounds having formula (I) is disclosed, wherein: - R1 is a methoxy or methylthio group; - R2 is a O-glycosyloxy residue. Compounds having formula (I) are prepared by reacting the corresponding precurso...  
WO/2009/139719
The present invention relates to novel synthesis routes for preparation of thiodigalactosides of the general formula (12). The method comprises the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corres...  
WO/2009/139719
The present invention relates to novel synthesis routes for preparation of thiodigalactosides of the general formula (12). The method comprises the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corres...  
WO/2009/135673
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/135673
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/135673
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/134570
Disclosed are tri-nuclear metal complexes and salts thereof, such as tri-nuclear osmium or ruthenium complexes or salts thereof, suitable for use as electrochemical labels. Also disclosed are oligonucleotide probes with an attached elect...  
WO/2009/134570
Disclosed are tri-nuclear metal complexes and salts thereof, such as tri-nuclear osmium or ruthenium complexes or salts thereof, suitable for use as electrochemical labels. Also disclosed are oligonucleotide probes with an attached elect...  
WO/2009/133269
The invention relates to compounds of the formula (I) in which R1, R2 and R3 are identical or different and each represent a hydrogen atom or a group of the formula (A). The invention can be used for drugs.  
WO/2009/127339
The present invention relates to nanoemulsions comprising alkyl and/or alkenyl ethers of alkyl and/or alkenyl(poly)glycosides, a method for the production thereof and use thereof. The present invention further relates to alkyl and/or alk...  
WO/2009/125819
Disclosed is a compound useful as an active ingredient for a pharmaceutical composition having an α-amylase-inhibiting activity, particularly a pharmaceutical composition for the treatment of diabetes. Studies have been made for discove...  
WO/2009/126556
Compounds, compositions and methods are provided for treatment of diseases or complications associated therewith, in which a selectin plays a role. More specifically, particular glycomimetics and uses thereof are described. For example, ...  
WO/2009/126737
The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin ...  
WO/2009/126737
The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin ...  
WO/2009/124468
Anthracycline antibiotic derivatives with anticancer activity, i.e. the compounds of formula (I). The present anthracycline antibiotic derivatives has the same activity as or higher activity than that of the known medicaments such as dox...  
WO/2009/121939
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers,...  
WO/2009/121939
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers,...  
WO/2009/119692
Disclosed are: a novel glycolipid effective for the treatment of caner or the like; a novel intermediate for the synthesis of the novel glycolipid; a pharmaceutical agent comprising the novel glycolipid; and others. Specifically disclose...  
WO/2009/117196
Methods for utilizing the anticancer properties of terpenoid saponin compounds so as to modulate adhesion proteins, inhibit angiogenesis in tumors, modulate gene expression, modulate angiopoietin, enhance an immune response, provide adju...  
WO/2009/117196
Methods for utilizing the anticancer properties of terpenoid saponin compounds so as to modulate adhesion proteins, inhibit angiogenesis in tumors, modulate gene expression, modulate angiopoietin, enhance an immune response, provide adju...  
WO/2009/112951
Method for preparing the disaccharide [α-D-Gldp(1→3)]-α-L-Rhap-YR wherein Y is selected from -O- and -S- and R is selected from the group consisting of: C1-C6 alkyl, C1-C6 alkenyl, aryl, allyl, -CO-alkyl (C1-C6), -CO-alkenyl (C1-C6),...  
WO/2009/112950
Method for preparing the disaccharide α-D-glucopyranosyl-(1→4)- 2-N-acetyl-2-deoxy-α-D-glucopyranoside, comprising the step of using a mutant of a wild type glycoside hydrolase.  
WO/2009/107853
An agent for preventing or ameliorating skin aging, which exhibits a more excellent effect on the suppression of formation, or the amelioration, of wrinkles on the skin or sagging skin. An agent for preventing or ameliorating skin aging,...  

Matches 351 - 400 out of 6,401